NASDAQ : SRZN
Surrozen, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 29.46 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 515.41M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Surrozen, Inc. (SRZN) reported revenue of 11.51M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 11.51M | 3.48M | 10.65M | 12.50M | ||
| Cost of Revenue | 34.58M | 29.36M | 21.13M | 27.23M | 37.01M | 40.18M |
| Gross Profit | -23.07M | -25.89M | -10.48M | -27.23M | -24.51M | -40.18M |
| Selling, General & Admin | 21.28M | 16.20M | 15.06M | 15.80M | 19.83M | 14.21M |
| Operating Expenses | 21.28M | 16.20M | 15.06M | 15.80M | 19.83M | 14.21M |
| Operating Income | -44.35M | -42.09M | -25.54M | -43.03M | -44.34M | -54.39M |
| Interest & Investment Income | 3.55M | 3.02M | 1.69M | 2.34M | 781.00K | 72.00K |
| Other Non Operating Income (Expenses) | -291.33M | -202.95M | -39.72M | 398.00K | 7.55M | -329.00K |
| EBT Excluding Unusual Items | -332.13M | -242.03M | -63.56M | -40.29M | -36.00M | -54.65M |
| Merger & Restructuring Charges | -2.75M | |||||
| Pretax Income | -332.13M | -242.03M | -63.56M | -43.04M | -36.00M | -54.65M |
| Net Income | -332.13M | -242.03M | -63.56M | -43.04M | -36.00M | -54.65M |
| Net Income to Common | -324.56M | -242.03M | -63.56M | -43.04M | -36.00M | -54.65M |
| Shares Outstanding (Basic) | 10.08M | 7.48M | 2.93M | 2.02M | 2.31M | 1.65M |
| Shares Outstanding (Diluted) | 10.08M | 7.48M | 2.93M | 2.02M | 2.31M | 1.65M |
| EPS (Basic) | -32.19 | -32.37 | -21.67 | -21.33 | -15.56 | -33.20 |
| EPS (Diluted) | -32.19 | -32.37 | -21.67 | -21.33 | -15.56 | -33.20 |
| Free Cash Flow | -34.98M | -30.37M | -17.65M | -40.76M | -44.87M | -50.08M |
| Free Cash Flow Per Share | -3.47 | -4.06 | -6.02 | -20.20 | -19.39 | -30.43 |
| Gross Margin | -200.38% | -98.33% | -196.10% | |||
| Operating Margin | -385.28% | -1,210.58% | -239.69% | -354.71% | ||
| Profit Margin | -2,819.60% | -6,960.77% | -596.57% | -288.03% | ||
| Free Cash Flow Margin | -303.92% | -873.51% | -165.69% | -358.98% | ||
| EBITDA | -44.13M | -41.55M | -24.10M | -41.12M | -42.38M | -52.33M |
| EBITDA Margin | -226.16% | |||||
| D&A For EBITDA | 222.00K | 537.00K | 1.44M | 1.91M | 1.96M | 2.07M |
| EBIT | -44.35M | -42.09M | -25.54M | -43.03M | -44.34M | -54.39M |
| EBIT Margin | -239.69% | |||||
| Revenue as Reported | 11.51M | 3.48M | 10.65M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 102.04M | 89.25M | 34.56M | 36.04M | 24.69M | 33.09M |
| Short-Term Investments | 51.15M | 68.76M | ||||
| Cash & Short-Term Investments | 102.04M | 89.25M | 34.56M | 36.04M | 75.84M | 101.85M |
| Receivables | 5.00M | 208.00K | 2.54M | 2.15M | 1.98M | |
| Prepaid Expenses | 2.36M | 2.11M | 1.83M | 606.00K | 1.08M | 3.34M |
| Other Current Assets | 2.33M | 2.41M | ||||
| Total Current Assets | 109.40M | 91.56M | 38.93M | 41.13M | 81.31M | 105.19M |
| Property, Plant & Equipment | 5.56M | 6.43M | 8.36M | 3.86M | 6.90M | 9.38M |
| Long-Term Investments | 21.66M | |||||
| Other Long-Term Assets | 650.00K | 734.00K | 1.17M | 1.09M | 1.23M | 954.00K |
| Total Assets | 115.61M | 98.73M | 48.47M | 46.08M | 89.44M | 137.17M |
| Accounts Payable | 1.07M | 728.00K | 306.00K | 525.00K | 658.00K | 2.72M |
| Accrued Expenses | 5.52M | 7.62M | 4.99M | 3.83M | 6.27M | 8.07M |
| Current Portion of Leases | 1.99M | 1.29M | 1.83M | 2.50M | 2.23M | 2.19M |
| Other Current Liabilities | 434.00K | 289.00K | 191.00K | 292.00K | 581.00K | 589.00K |
| Total Current Liabilities | 9.01M | 9.93M | 7.32M | 7.15M | 9.73M | 13.57M |
| Long-Term Leases | 4.33M | 5.35M | 6.64M | 882.00K | 3.38M | 5.60M |
| Other Long-Term Liabilities | 320.93M | 271.21M | 55.89M | 115.00K | 326.00K | 8.30M |
| Total Liabilities | 334.27M | 286.49M | 69.85M | 8.14M | 13.43M | 27.47M |
| Common Stock | 1.00K | 1.00K | 4.00K | |||
| Additional Paid-In Capital | 385.95M | 339.52M | 263.88M | 259.63M | 254.90M | 252.46M |
| Retained Earnings | -604.61M | -527.28M | -285.26M | -221.69M | -178.65M | -142.65M |
| Comprehensive Income & Other | -241.00K | -119.00K | ||||
| Total Common Equity | -218.66M | -187.76M | -21.38M | 37.94M | 76.00M | 109.70M |
| Shareholders' Equity | -218.66M | -187.76M | -21.38M | 37.94M | 76.00M | 109.70M |
| Total Liabilities & Equity | 115.61M | 98.73M | 48.47M | 46.08M | 89.44M | 137.17M |
| Total Debt | 6.32M | 6.64M | 8.47M | 3.38M | 5.60M | 7.79M |
| Net Cash (Debt) | 95.72M | 82.61M | 26.10M | 32.66M | 70.24M | 115.71M |
| Net Cash Per Share | 9.49 | 11.05 | 8.90 | 16.19 | 30.35 | 70.30 |
| Filing Date Shares Outstanding | 11.75M | 11.49M | 3.28M | 3.20M | 2.01M | 2.34M |
| Total Common Shares Outstanding | 11.75M | 9.77M | 3.26M | 2.06M | 2.01M | 2.34M |
| Working Capital | 100.39M | 81.63M | 31.62M | 33.98M | 71.57M | 91.62M |
| Book Value Per Share | -18.60 | -19.21 | -6.55 | 18.39 | 37.89 | 46.97 |
| Tangible Book Value | -218.66M | -187.76M | -21.38M | 37.94M | 76.00M | 109.70M |
| Tangible Book Value Per Share | -18.60 | -19.21 | -6.55 | 18.39 | 37.89 | 46.97 |
| Machinery | 7.69M | 7.29M | 8.22M | 7.93M | 7.28M | |
| Leasehold Improvements | 1.12M | 1.12M | 1.12M | 7.05M | 7.05M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -332.13M | -242.03M | -63.56M | -43.04M | -36.00M | -54.65M |
| Depreciation & Amortization | 222.00K | 537.00K | 1.44M | 1.91M | 1.96M | 2.07M |
| Asset Writedown & Restructuring Costs | 169.00K | |||||
| Loss (Gain) From Sale of Investments | -732.00K | 108.00K | 105.00K | |||
| Stock-Based Compensation | 7.00M | 3.83M | 4.11M | 4.37M | 4.52M | 2.32M |
| Other Operating Activities | 293.10M | 204.26M | 41.22M | 888.00K | -6.30M | 1.57M |
| Change in Accounts Receivable | -2.71M | 2.33M | -502.00K | -1.98M | ||
| Change in Accounts Payable | 439.00K | 142.00K | -228.00K | -133.00K | -2.04M | 857.00K |
| Change in Other Net Operating Assets | -686.00K | 678.00K | -106.00K | -3.80M | -4.40M | -1.08M |
| Operating Cash Flow | -34.76M | -30.24M | -17.63M | -40.36M | -44.15M | -48.81M |
| Capital Expenditures | -222.00K | -128.00K | -26.00K | -398.00K | -728.00K | -1.27M |
| Investment in Securities | 52.12M | 39.04M | -76.44M | |||
| Investing Cash Flow | -222.00K | -128.00K | -26.00K | 51.72M | 38.31M | -77.71M |
| Issuance of Common Stock | 46.58M | 85.05M | 16.18M | 335.00K | 143.00K | 124.63M |
| Repurchase of Common Stock | -59.00K | -2.62M | -1.00K | |||
| Other Financing Activities | -85.00K | |||||
| Financing Cash Flow | 46.58M | 85.05M | 16.18M | 276.00K | -2.56M | 124.63M |
| Net Cash Flow | 11.60M | 54.68M | -1.48M | 11.64M | -8.40M | -1.89M |
| Free Cash Flow | -34.98M | -30.37M | -17.65M | -40.76M | -44.87M | -50.08M |
| Free Cash Flow Margin | -303.92% | -873.51% | -165.69% | -358.98% | ||
| Free Cash Flow Per Share | -3.47 | -4.06 | -6.02 | -20.20 | -19.39 | -30.43 |
| Levered Free Cash Flow | -21.75M | -16.86M | -8.87M | -23.48M | -27.97M | -26.97M |
| Unlevered Free Cash Flow | -21.75M | -16.86M | -8.87M | -23.48M | -27.97M | -26.97M |
| Change in Working Capital | -2.96M | 3.15M | -836.00K | -3.93M | -8.42M | -221.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 508.06M | 210.69M | 46.63M | 19.16M | 17.31M | 225.58M |
| Enterprise Value | 412.34M | 136.44M | 17.15M | -20.31M | -54.97M | 123.68M |
| Last Close Price | 29.04 | 22.60 | 14.35 | 9.40 | 8.73 | 96.60 |
| PS Ratio | 44.14 | 60.60 | 4.38 | 1.38 | ||
| PB Ratio | -1.12 | -2.18 | 0.51 | 0.23 | 2.06 | |
| P/TBV Ratio | 0.51 | 0.23 | 2.06 | |||
| EV/Sales Ratio | 35.82 | 39.24 | 1.61 | |||
| Debt / Equity Ratio | -0.03 | -0.04 | -0.40 | 0.09 | 0.07 | 0.07 |
| Net Debt / Equity Ratio | 0.44 | 0.44 | 1.22 | -0.86 | -0.92 | -1.05 |
| Net Debt / EBITDA Ratio | 2.17 | 1.99 | 1.08 | 0.79 | 1.66 | 2.21 |
| Net Debt / FCF Ratio | 2.74 | 2.72 | 1.48 | 0.80 | 1.56 | 2.31 |
| Asset Turnover | 0.10 | 0.05 | 0.23 | 0.11 | ||
| Quick Ratio | 11.88 | 9.01 | 5.07 | 5.34 | 8.00 | 7.50 |
| Current Ratio | 12.14 | 9.22 | 5.32 | 5.75 | 8.35 | 7.75 |
| Return on Equity (ROE) | -767.91% | -75.56% | -38.78% | -69.62% | ||
| Return on Assets (ROA) | -25.39% | -35.74% | -33.77% | -39.69% | -24.46% | -34.12% |
| Return on Capital Employed (ROCE) | -41.60% | -47.40% | -62.10% | -110.50% | -55.60% | -44.00% |
| Earnings Yield | -110.84% | -114.87% | -136.30% | -224.64% | -208.04% | -24.23% |
| FCF Yield | -6.89% | -14.41% | -37.86% | -212.74% | -259.29% | -22.20% |
| Buyback Yield / Dilution | -115.86% | -154.96% | -45.34% | 12.79% | -40.59% | -54.57% |